Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”

Circulation. 2013 Mar 19;127(11):e506. doi: 10.1161/circulationaha.112.154732.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anticoagulants / adverse effects*
  • Benzimidazoles / adverse effects*
  • Female
  • Hemorrhage / chemically induced*
  • Humans
  • Male
  • Thromboembolism / drug therapy*
  • Warfarin / adverse effects*
  • beta-Alanine / analogs & derivatives*

Substances

  • Anticoagulants
  • Benzimidazoles
  • beta-Alanine
  • Warfarin